Skip to main content

Advertisement

Log in

Current Status of Minimally Invasive Surgery for Renal Cell Carcinoma

  • Minimally Invasive Surgery (T Guzzo, Section Editor)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Over the last three decades, the incidence of renal cell carcinoma (RCC) has continuously risen, generally attributed to the increased use of cross-sectional imaging across all medical disciplines. Fortunately, despite this rising incidence, the estimated 5-year relative survival rate has improved. This survival improvement likely parallels the stage migration of the last two decades toward an increased incidence of small renal masses (SRMs). However, this survival improvement may be secondary to improved surgical techniques and medical therapies for these malignancies. The increased incidence of SRMs has led to an expected evolution in the treatment of RCC. Minimally invasive surgical applications for the treatment of RCC have gained widespread popularity, and now these approaches to renal malignancies have surpassed open techniques in frequency of utilization. Laparoscopic and robotic-assisted techniques have now been applied to both radical and partial nephrectomy procedures of varying complexity. Additionally, percutaneous ablative procedures have been applied to the treatment of some SRMs, increasing the urologist’s armamentarium further. Below, we provide a review of these minimally invasive surgical (MIS) procedures for the treatment of RCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. doi:10.3322/caac.21254.

    Article  PubMed  Google Scholar 

  2. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993;328:1237–43. doi:10.1056/NEJM199304293281706.

    Article  CAS  PubMed  Google Scholar 

  3. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331–4. doi:10.1093/jnci/djj362.

    Article  PubMed  Google Scholar 

  4. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008;113:78–83. doi:10.1002/cncr.23518.

    Article  PubMed  Google Scholar 

  5. Ficarra V, Galfano A, Cavalleri S. Is simple enucleation a minimal partial nephrectomy responding to the EAU guidelines’ recommendations? Eur Urol. 2009;55:1315–8. doi:10.1016/j.eururo.2008.08.067.

    Article  PubMed  Google Scholar 

  6. Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al. EAU Guidelines on Renal Cell Carcinoma: 2014 Update. Eur Urol. 2015. doi:10.1016/j.eururo.2015.01.005.

    Google Scholar 

  7. Kutikov A, Smaldone MC, Egleston BL, Uzzo RG. Should partial nephrectomy be offered to all patients whenever technically feasible? Eur Urol. 2012;61:732–4. doi:10.1016/j.eururo.2011.12.014. discussion734–5.

    Article  PubMed  Google Scholar 

  8. Heuer R, Gill IS, Guazzoni G, Kirkali Z, Marberger M, Richie JP, et al. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer. Eur Urol. 2010;57:223–32. doi:10.1016/j.eururo.2009.10.023.

    Article  PubMed  Google Scholar 

  9. Van Poppel H, Becker F, Cadeddu JA, Gill IS, Janetschek G, Jewett MAS, et al. Treatment of localised renal cell carcinoma. Eur Urol. 2011;60:662–72. doi:10.1016/j.eururo.2011.06.040.

    Article  PubMed  Google Scholar 

  10. Sun M, Trinh Q-D, Bianchi M, Hansen J, Hanna N, Abdollah F, et al. A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol. 2012;61:725–31. doi:10.1016/j.eururo.2011.11.047.

    Article  PubMed  Google Scholar 

  11. Scosyrev E, Messing EM, Sylvester R, Campbell S, Van Poppel H. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol. 2014;65:372–7. doi:10.1016/j.eururo.2013.06.044. This post hoc analysis of EORTC 30904 showed a significant advantage in postoperative CKD with PN over RN.

    Article  PubMed  Google Scholar 

  12. Laviana AA, Hu JC. Current controversies and challenges in robotic-assisted, laparoscopic, and open partial nephrectomies. World J Urol. 2014;32:591–6. doi:10.1007/s00345-014-1277-6.

    Article  PubMed  Google Scholar 

  13. Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182:844–53. doi:10.1016/j.juro.2009.05.035.

    Article  PubMed  Google Scholar 

  14. Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol. 2009;56:786–93. doi:10.1016/j.eururo.2009.07.040.

    Article  PubMed  Google Scholar 

  15. Simmons MN, Ching CB, Samplaski MK, Park CH, Gill IS. Kidney tumor location measurement using the C index method. J Urol. 2010;183:1708–13. doi:10.1016/j.juro.2010.01.005.

    Article  PubMed  Google Scholar 

  16. Leslie S, Gill IS, de Castro Abreu AL, Rahmanuddin S, Gill KS, Nguyen M, et al. Renal tumor contact surface area: a novel parameter for predicting complexity and outcomes of partial nephrectomy. Eur Urol. 2014;66:884–93. doi:10.1016/j.eururo.2014.03.010.

    Article  PubMed  Google Scholar 

  17. Clayman RV, Kavoussi LR, Soper NJ, Dierks SM, Meretyk S, Darcy MD, et al. Laparoscopic nephrectomy: initial case report. Juro. 1991;146:278–82.

    CAS  Google Scholar 

  18. Flanigan RC, Mickisch G, Sylvester R, Tangen C, van Poppel H, Crawford ED. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. Juro. 2004;171:1071–6. doi:10.1097/01.ju.0000110610.61545.ae.

    Google Scholar 

  19. Gershman B, Moreira DM, Boorjian SA, Lohse CM, Cheville JC, Costello BA, et al. Comprehensive characterization of the perioperative morbidity of cytoreductive nephrectomy. Eur Urol. 2015. doi:10.1016/j.eururo.2015.05.022.

    Google Scholar 

  20. Trinh Q-D, Bianchi M, Hansen J, Tian Z, Abdollah F, Shariat SF, et al. In-hospital mortality and failure to rescue after cytoreductive nephrectomy. Eur Urol. 2013;63:1107–14. doi:10.1016/j.eururo.2012.08.069.

    Article  PubMed  Google Scholar 

  21. Peri L, Musquera M, Vilaseca A, Garcia-Cruz E, Ribal MJ, Carrión A, et al. Perioperative outcome and female sexual function after laparoscopic transvaginal NOTES-assisted nephrectomy. World J Urol. 2015;33:2009–14. doi:10.1007/s00345-015-1573-9.

    Article  PubMed  Google Scholar 

  22. Xue Y, Zou X, Zhang G, Yuan Y, Xiao R, Liao Y, et al. Transvaginal natural orifice transluminal endoscopic nephrectomy in a series of 63 cases: stepwise transition from hybrid to pure NOTES. Eur Urol. 2015;68:302–10. doi:10.1016/j.eururo.2015.03.033.

    Article  PubMed  Google Scholar 

  23. Navarro R, Tanguy R, Terrier J-E, Golfier F, Ruffion A, Paparel P. Does laparoscopic nephrectomy with vaginal extraction affect the sexual quality of life of patients? Prog Urol. 2015;25:1153–9. doi:10.1016/j.purol.2015.09.004.

    Article  CAS  PubMed  Google Scholar 

  24. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004;94:33–41. doi:10.1111/j.1464-410X.2004.04897.x.

    Article  PubMed  Google Scholar 

  25. Glazer AA, Novick AC. Long-term followup after surgical treatment for renal cell carcinoma extending into the right atrium. Juro. 1996;155:448–50.

    CAS  Google Scholar 

  26. Pouliot F, Shuch B, Larochelle JC, Pantuck A, Belldegrun AS. Contemporary management of renal tumors with venous tumor thrombus. J Urol. 2010;184:833–41. doi:10.1016/j.juro.2010.04.071. quiz1235.

    Article  PubMed  Google Scholar 

  27. Ciancio G, Manoharan M, Katkoori D, De Los Santos R, Soloway MS. Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience. Eur Urol. 2010;57:667–72. doi:10.1016/j.eururo.2009.06.009.

    Article  PubMed  Google Scholar 

  28. Varkarakis IM, Bhayani SB, Allaf ME, Inagaki T, Gonzalgo ML, Jarrett TW. Laparoscopic-assisted nephrectomy with inferior vena cava tumor thrombectomy: preliminary results. Urology. 2004;64:925–9. doi:10.1016/j.urology.2004.05.044.

    Article  PubMed  Google Scholar 

  29. Romero FR, Muntener M, Bagga HS, Brito FAR, Sulman A, Jarrett TW. Pure laparoscopic radical nephrectomy with level II vena caval thrombectomy. Urology. 2006;68:1112–4. doi:10.1016/j.urology.2006.08.1084.

    Article  PubMed  Google Scholar 

  30. Martin GL, Castle EP, Martin AD, Desai PJ, Lallas CD, Ferrigni RG, et al. Outcomes of laparoscopic radical nephrectomy in the setting of vena caval and renal vein thrombus: seven-year experience. J Endourol. 2008;22:1681–5. doi:10.1089/end.2008.0035.

    Article  PubMed  Google Scholar 

  31. Abaza R, Shabsigh A, Castle E, Allaf M, Hu JC, Rogers C, et al. Multi-institutional experience with robotic nephrectomy with IVC tumor thrombectomy. J Urol. 2015. doi:10.1016/j.juro.2015.09.094. This is the first multi-institutional study to present a series of robotic nephrectomy with IVC thrombectomy.

    Google Scholar 

  32. Gill IS, Metcalfe C, Abreu A, Duddalwar V, Chopra S, Cunningham M, et al. Robotic level III inferior vena cava tumor thrombectomy: initial series. J Urol. 2015;194:929–38. doi:10.1016/j.juro.2015.03.119.

    Article  PubMed  Google Scholar 

  33. Novick AC. The role of renal-sparing surgery for renal cell carcinoma. Semin Urol. 1992;10:12–5.

    CAS  PubMed  Google Scholar 

  34. Crepel M, Jeldres C, Sun M, Lughezzani G, Isbarn H, Alasker A, et al. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma. Urology. 2010;76:883–8. doi:10.1016/j.urology.2009.08.028.

    Article  PubMed  Google Scholar 

  35. Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int. 2007;100:1235–9. doi:10.1111/j.1464-410X.2007.07225.x.

    Article  PubMed  Google Scholar 

  36. Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182:1271–9. doi:10.1016/j.juro.2009.07.004.

    Article  PubMed  Google Scholar 

  37. Long CJ, Canter DJ, Kutikov A, Li T, Simhan J, Smaldone M, et al. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. BJU Int. 2012;109:1450–6. doi:10.1111/j.1464-410X.2011.10608.x.

    Article  PubMed  Google Scholar 

  38. Kopp RP, Mehrazin R, Palazzi KL, Liss MA, Jabaji R, Mirheydar HS, et al. Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score. BJU Int. 2014;114:708–18. doi:10.1111/bju.12580.

    Article  PubMed  Google Scholar 

  39. McDougall EM, Clayman RV, Anderson K. Laparoscopic wedge resection of a renal tumor: initial experience. J Laparoendosc Surg. 1993;3:577–81.

    Article  CAS  PubMed  Google Scholar 

  40. Link RE, Bhayani SB, Allaf ME, Varkarakis I, Inagaki T, Rogers C, et al. Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. Juro. 2005;173:1690–4. doi:10.1097/01.ju.0000154777.24753.1b.

    Google Scholar 

  41. Abouassaly R, Alibhai SMH, Tomlinson G, Timilshina N, Finelli A. Unintended consequences of laparoscopic surgery on partial nephrectomy for kidney cancer. J Urol. 2010;183:467–72. doi:10.1016/j.juro.2009.10.002.

    Article  PubMed  Google Scholar 

  42. Patel HD, Mullins JK, Pierorazio PM, Jayram G, Cohen JE, Matlaga BR, et al. Trends in renal surgery: robotic technology is associated with increased use of partial nephrectomy. J Urol. 2013;189:1229–35. doi:10.1016/j.juro.2012.10.024.

    Article  PubMed  Google Scholar 

  43. Kardos SV, Gross CP, Shah ND, Schulam PG, Trinh Q-D, Smaldone MC, et al. Association of type of renal surgery and access to robotic technology for kidney cancer: results from a population-based cohort. BJU Int. 2014;114:549–54. doi:10.1111/bju.12711.

    Article  PubMed  Google Scholar 

  44. Shiroki R, Fukami N, Fukaya K, Kusaka M, Natsume T, Ichihara T, et al. Robot-assisted partial nephrectomy: Superiority over laparoscopic partial nephrectomy. Int J Urol. 2015:n/a–n/a. doi:10.1111/iju.13001.

  45. Carneiro A, Sivaraman A, Sanchez-Salas R, Di Trapani E, Barret E, Rozet F, et al. Evolution from laparoscopic to robotic nephron sparing surgery: a high-volume laparoscopic center experience on achieving “trifecta” outcomes. World J Urol. 2015;33:2039–44. doi:10.1007/s00345-015-1552-1.

    Article  PubMed  Google Scholar 

  46. Mir MC, Ercole C, Takagi T, Zhang Z, Velet L, Remer EM, et al. Decline in renal function after partial nephrectomy: etiology and prevention. J Urol. 2015;193:1889–98. doi:10.1016/j.juro.2015.01.093.

    Article  PubMed  Google Scholar 

  47. Lane BR, Russo P, Uzzo RG, Hernandez AV, Boorjian SA, Thompson RH, et al. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol. 2011;185:421–7. doi:10.1016/j.juro.2010.09.131.

    Article  PubMed  Google Scholar 

  48. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, et al. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol. 2010;58:340–5. doi:10.1016/j.eururo.2010.05.047.

    Article  PubMed  Google Scholar 

  49. Nguyen MM, Gill IS. Halving ischemia time during laparoscopic partial nephrectomy. J Urol. 2008;179:627–32. doi:10.1016/j.juro.2007.09.086. discussion632.

    Article  PubMed  Google Scholar 

  50. Peyronnet B, Baumert H, Mathieu R, Masson-Lecomte A, Grassano Y, Roumiguié M, et al. Early unclamping technique during robot-assisted laparoscopic partial nephrectomy can minimise warm ischaemia without increasing morbidity. BJU Int. 2014;114:741–7. doi:10.1111/bju.12766.

    Article  PubMed  Google Scholar 

  51. Zhou L, Wei X, Sun W-J, Liu Q, Jian Z-Y, Li H, et al. Selective versus hilar clamping during minimally invasive partial nephrectomy: a systematic review and meta-analysis. J Endourol. 2015;29:855–63. doi:10.1089/end.2014.0878.

    Article  PubMed  Google Scholar 

  52. Desai MM, de Castro Abreu AL, Leslie S, Cai J, Huang EY-H, Lewandowski P-M, et al. Robotic partial nephrectomy with superselective versus main artery clamping: a retrospective comparison. Eur Urol. 2014;66:713–9. doi:10.1016/j.eururo.2014.01.017.

    Article  PubMed  Google Scholar 

  53. Ramirez D, Caputo P, Krishnan J, Zargar H, Kaouk JH. Robotic partial nephrectomy with intracorporeal renal hypothermia using ice slush: step-by-step technique and matched comparison to warm ischemia. BJU Int. 2015. doi:10.1111/bju.13346.

    Google Scholar 

  54. Parekh DJ, Weinberg JM, Ercole B, Torkko KC, Hilton W, Bennett M, et al. Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol. 2013;24:506–17. doi:10.1681/ASN.2012080786. This in depth study challenged what is known about the nonneoplastic kidney’s tolerance to ischemia with detailed analysis of the impacts.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Kaczmarek BF, Sukumar S, Kumar RK, Desa N, Jost K, Diaz M, et al. Comparison of robotic and laparoscopic ultrasound probes for robotic partial nephrectomy. J Endourol. 2013;27:1137–40. doi:10.1089/end.2012.0528.

    Article  PubMed  Google Scholar 

  56. Bjurlin MA, McClintock TR, Stifelman MD. Near-infrared fluorescence imaging with intraoperative administration of indocyanine green for robotic partial nephrectomy. Curr Urol Rep. 2015;16:20–7. doi:10.1007/s11934-015-0495-9.

    Article  PubMed  Google Scholar 

  57. Zargar H, Atwell TD, Cadeddu JA, la Rosette de JJ, Janetschek G, Kaouk JH, et al. Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results. Eur Urol. 2015. doi:10.1016/j.eururo.2015.03.027.

  58. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer. 2010;116:3135–42. doi:10.1002/cncr.25002.

    Article  PubMed  Google Scholar 

  59. Levinson AW, Su L-M, Agarwal D, Sroka M, Jarrett TW, Kavoussi LR, et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol. 2008;180:499–504. doi:10.1016/j.juro.2008.04.031. discussion504.

    Article  PubMed  Google Scholar 

  60. Klatte T, Kroeger N, Zimmermann U, Burchardt M, Belldegrun AS, Pantuck AJ. The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation. World J Urol. 2014;32:597–605. doi:10.1007/s00345-014-1284-7.

    Article  PubMed  Google Scholar 

  61. Klatte T, Shariat SF, Remzi M. Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors. J Urol. 2014;191:1209–17. doi:10.1016/j.juro.2013.11.006.

    Article  PubMed  Google Scholar 

  62. Whitson JM, Harris CR, Meng MV. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses. BJU Int. 2012;110:1438–43. doi:10.1111/j.1464-410X.2012.11113.x. discussion1443.

    Article  PubMed  Google Scholar 

  63. Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer. 2008;113:2671–80. doi:10.1002/cncr.23896.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Zargar H, Samarasekera D, Khalifeh A, Remer EM, O’Malley C, Akca O, et al. Laparoscopic vs percutaneous cryoablation for the small renal mass: 15-year experience at a single center. Urology. 2015;85:850–5. doi:10.1016/j.urology.2015.01.004.

    Article  PubMed  Google Scholar 

  65. Klatte T, Marberger M. High-intensity focused ultrasound for the treatment of renal masses: current status and future potential. Curr Opin Urol. 2009;19:188–91. doi:10.1097/MOU.0b013e328323f641.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zachary L. Smith.

Ethics declarations

Conflict of Interest

Zachary L. Smith declares no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Minimally Invasive Surgery

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith, Z.L. Current Status of Minimally Invasive Surgery for Renal Cell Carcinoma. Curr Urol Rep 17, 43 (2016). https://doi.org/10.1007/s11934-016-0599-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11934-016-0599-x

Keywords

Navigation